Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case–control study, influenza season 2012/13-Reference-Cited by-同舟云学术

Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case–control study, influenza season 2012/13

Published:2014-02-13 Issue:6 Volume:19 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Kissling E¹²,Valenciano M²¹,Buchholz U³,Larrauri A⁴,Cohen J M⁵,Nunes B⁶,Rogalska J⁷⁸,Pitigoi D⁹¹⁰,Paradowska-Stankiewicz I¹¹,Reuss A³,Jiménez-Jorge S⁴,Daviaud I⁵,Guiomar R⁶,O’Donnell J⁸,Necula G¹⁰,Głuchowska M¹¹,Moren A¹

Affiliation:

1. EpiConcept, Paris, France

2. These authors contributed equally to this work as first author

3. Robert Koch-Institute, Berlin, Germany

4. National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain

5. GROG/Open Rome, Paris, France

6. Instituto Nacional de Saude Dr Ricardo Jorge, Lisbon, Portugal

7. European Programme for Intervention Epidemiology Training (EPIET), European

8. Health Protection Surveillance Centre, Dublin, Ireland

9. Universitatea de Medicina si Farmacie Carol Davila, Bucharest, Romania

10. Cantacuzino Institute, National Institute of Research – Development for Microbiology

11. National Institute for Public Health, Warsaw, Poland

Abstract

Binary file ES_Abstracts_Final_ECDC.txt matches

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference29 articles.

1. European Centre for Disease Prevention and Control (ECDC). Influenza virus characterisation. Stockholm: ECDC; Jul 2013. Available from: http://ecdc.europa.eu/en/publications/Publications/influenza-virus-characterisation-July-2013.pdf

2. World Health Organisation (WHO). Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Geneva: WHO; Feb 2012. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201202_recommendation.pdf

3. Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, Pitigoi D, et al. "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill. 2009;14(44):pii: 19388.

4. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013;18(5):pii: 20390.

5. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe. PLoS ONE 6(11): e27622.

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines;Human Vaccines & Immunotherapeutics;2024-04-15

2. Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study;Influenza and Other Respiratory Viruses;2024-01

3. Vaccine or Garlic–Is It a Choice? Awareness of Medical Personnel on Prevention of Influenza Infections;Vaccines;2022-12-28

4. Digitalizing and Upgrading Severe Acute Respiratory Infections Surveillance in Malta: System Development;JMIR Public Health and Surveillance;2022-12-05

5. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study;Influenza and Other Respiratory Viruses;2022-11-21